Abstract
Introduction

Transcriptional regulation is the first and vital step in the unified flow of biological information and is governed by (i) the context of cis-regulatory regions (cis-motifs residing within promoters, distant enhancers and silencers) and (ii) functional interactions between the products of specific regulatory genes (transcription factors-TFs) and cis-motifs [1]. Gaining insight into the orchestrated assembly and synergistic interplay of transcriptional regulatory mechanisms have been a challenging and burgeoning effort and much progress has been made since the preliminary deciphering of the human genome [2, 3]. Advances in high-throughput microarray and chromatin immunoprecipitation (ChIP) technologies have gained much momentum [4], but these systems are unable on their own to reveal new insights into the combinatorial and conserved nature of transcription. Whole-genome sequence data integrated with high-throughput technologies and complemented by systematic computational (in silico) strategies have set the stage for functional genomics (Fig. 1). Genome-wide functional analysis has allowed researchers to gain and predict a holistic view of the regulatory networks controlling gene expression and, although at a slower pace than anticipated, holds much promise in advancing post-genomic biomedical research
 [5] [6] [7] [8] [9] 
. Endeavours to decipher the principles of transcriptional regulation involve comprehensive interactions from different data systems on different levels that are managed, processed and modelled by integrative in silico tools combining database-assistance and motif detection algorithms. Numerous systematic integration and modelling strategies have been developed to elucidate the factors that contribute to the complexity of gene regulation within a network of genomic circuits. However, most of these approaches comprise of a relative general integration design combining high-throughput gene expression analysis, promoter data and bioinformatics.
The scope of high-throughput technologies and transcriptional regulatory network analysis is too large to be covered here, and has been reviewed elsewhere [4, [10] [11] [12] 
Combined in silico strategies contribute to accurate deciphering
Promoters hold the key to understanding and functional interpretation of the regulatory factors in cis and trans that control the site and level of gene activity [13] [14] [15] [16] [17] [18] . It has become progressively more evident that accurate analysis and in silico modelling of promoter architecture and regulatory networks could assist in the study and prediction of disease-state regulatory processes, novel therapeutic targets and consequently facilitate pharmaceutical drug design [9, 12, [19] [20] [21] [22] [23] [24] [25] . Numerous other elements i.e. co-regulators, chromatin modulators and the presence of bi-directional and alternative promoters, contribute to the complexity (and diversity) of transcriptional regulation [18] and poses a significant challenge for accurate promoter detection and analysis. Therefore, the reliability and accuracy of promoter modelling strategies relies heavily on computational methods to detect over-representation of 'true' cis-motifs in highly conserved modules that in turn could be used to study or accurately predict possible TFs modulating a group of genes expressed during a defined condition [11, 12, 21] [32] ) and Gibbs-sampling [33] are some of the most powerful and widely used algorithms (Fig. 3A) to detect motifs within a so-called 'noisy' background. These methods perform maximum likelihood estimates to identify statistical over-represented motifs in the highest scoring sequence alignments. In parallel, multi-species conservation analysis combined with predicted cis-motif clustering can be performed using the regulatory visualization tool for alignment (rVISTA) [34] computational platform (Fig. 3B ). This is a hypothesis-driven strategy, which states that cis-regulatory motifs within evolutionary conserved sequences are more likely to be functional compared to cis-motifs in non-conserved regions [35] . Currently the two major databases comprising comprehensive sets of TF-binding profiles are TRANSFAC [36] and JASPAR [37] .
TF-binding site database assistance allows for large-scale cismotif comparisons to consensus sequences or energy binding scores of experimentally validated TF-binding sites (Fig. 3C).
Binding scores are calculated from positional weight matrices (PWMs) that are derived from log-scale converted positional frequency matrices (PFMs) and these scores are directly related to DNA-protein binding energy interactions [27] . The extent to which the identified regulatory modules/motifs contribute to a specific interaction can be evaluated by modified array technologies (reviewed by Hoheisel [4] ) such as ChiP assays [29] . [29] . [7, 23, 24, 38] [43] , regulatory single nucleotide polymorphisms (SNPs) influencing antioxidant response elements [44] and tissue specificity [17, [45] [46] [47] . [48] , androgen receptor binding [49] , antibacterial response [50] , enterocyte differentiation [51] , human erythropoiesis [52] , alcohol-related apoptosis and cell proliferation [53] and methylation in prostate cancer [54] . Within this context, we specifically highlight a study by Freebern et al. [23] [16, 55 ]. An early model-based study by GailusDurner et al. [19] 
Putative identification and comparison of newly discovered TF-targets is restricted to the experimentally verified database entries, therefore it is imperative that TF-binding site databases are continuously updated. Nevertheless, the combined employment of computational tools integrated with biological data (extrapolated from high-throughput variations of validation techniques) is powerful and allows for a refined elucidation, comparison and prediction of cis-regulatory context
Systematic module analysis leads to target discovery
Several studies have successfully accentuated the strategy of systematic modelling in clinical applications to predict transcriptional targets by integration of in silico analysis and highthroughput technologies. These investigations identified the conserved organization of regulatory modules or targets that were implicated in distinct conditions and/or processes such as reovirus infection of human embryonic kidney cells
Applications of in silico promoters based on conserved regulatory context
Accurate interpretation of promoter architecture is dependent on underlying regulatory commonalities that exist for genes that are similar on the basis of expression, regulation and/or function. Moreover, (i ) combining expression data with functional annotation and (ii) the use of cis-regulatory module, rather than individual motif-information, can lead to a more defined predictive model design
Extrapolation of promoter data from genes expressed during a particular disease (transcriptomic profile represented by microarray) using (A) probabilistic motif detection algorithms i.e. MEME and Gibbs-sampling or (B) comparative phylogenetic promoter analysis across different species. (C)
Combining before-mentioned strategies with TF-database assistance (using TRANSFAC and/or JASPAR) for putative motif identification and representation. 
Fig. 4 In silico modelling strategy and implementation. (A) Combination of highly conserved promoter cis-motifs identified from genes expressed during a particular disease (transcriptomic profile represented by microarray) and used to construct promoter model. Specific promoter model can be implemented to identify novel genes (represented by red dots on underlying grey microarray) that can otherwise not be identified by conventional gene expression profile. (B) In addition, promoter model can be used to predict putative (i) regulatory pathways and (ii) TF-targets. This in silico bottom-up strategy is based on the concept of using a conserved regulatory promoter area (represented as a model) to predict (combining literature database mining) a central TF-target and/or so-called 'master regulator' (regulating a specific cascade of genes during a particular biological process). This information could be valuable for the development of a therapeutic agent affecting a central molecular regulator. analysis of the promoter framework (module organization) derived from genes distinctively expressed in the functional unit that contributes to the complex phenotype of the podocyte/slit-diaphragm, can provide direct links to identify a novel regulatory network by interaction of co-regulation and a related event (podocyte-directed expression
